retatrutide and blood sugar New GLP-3 drug significantly slashes both weight levels in Phase III trial Retatrutide Achieves Large Weight Decreases

Maybe GLP-1 drugs seem to do everything because obesity (and high blood sugar) are broadly bad for you, and anything that reduces obesity (or high blood sugar) is broadly good for you

References are at the end

placebo on the time to occurrence of a composite cardiovascular outcome (nonfatal myocardial infarction, nonfatal stroke, cardiovascular death, hospitalization or urgent visit due to heart failure) and a composite renal outcome (end-stage kidney disease, 40% sustained decline in eGFR, cardiovascular death or renal death) in 10,000 individuals with atherosclerotic cardiovascular disease and/or CKD

2 This is an important distinction

Oral semaglutide is effective for diabetes type 2 but has not been approved or studied extensively for weight loss